"10.1371_journal.pone.0024364","plos one","2011-09-08T00:00:00Z","Devon M Fitzgerald; Michael E Charness; Kimberly A Leite-Morris; Suzhen Chen","Veterans Affairs Boston Healthcare System, Boston, Massachusetts, United States of America; Department of Neurology, Harvard Medical School, West Roxbury, Massachusetts, United States of America; Boston University School of Medicine, Boston, Massachusetts, United States of America; Departments of Psychiatry, Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, United States of America","Conceived and designed the experiments: SC DF MC. Performed the experiments: DF SC KL-M. Analyzed the data: DF SC MC. Wrote the paper: DF SC MC.","MC is a member of the scientific advisory board for Allon Therapeutics, which is developing clinical applications for NAPVSIPQ (NAP). He holds stock in Allon Therapeutics. MC has two patents related to the study to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. 1. Charness ME and Wilkemeyer MF, co-inventors. “Antagonists of alcohol inhibition of cell adhesion.” US Patent 6,359,015, issued March 19, 2002. 2. Wilkemeyer MF and Charness ME, co-inventors “Method for antagonizing inhibition effects of alcohol on cell adhesion” US Patient 6,977,272 B2, issued December 20, 2005.","2011","09","Devon M Fitzgerald","DMF",4,TRUE,3,3,3,3,TRUE,TRUE,TRUE,1,"3",FALSE
